By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Ocular Therapeutix, Inc. 

204 Second Avenue

Waltham  Massachusetts  02451  U.S.A.
Phone: 781-895-3235 Fax: 781-895-3236


SEARCH JOBS


Industry
Biotechnology






Company News
Ocular Therapeutix (OCUL) Reports Inducement Grant Under NASDAQ Listing Rule 5635(C)(4) 6/26/2017 8:43:08 AM
Ocular Therapeutix (OCUL) Names Bristol-Myers Squibb (BMY)-Novartis AG (NVS) Vet As New CEO 6/23/2017 7:19:04 AM
Ocular Therapeutix (OCUL) Announces Executive Transition Plans 6/23/2017 6:21:10 AM
Ocular Therapeutix (OCUL) Presented Phase III Data For DEXTENZA At Association for Research in Vision & Ophthalmology Annual Meeting 5/11/2017 8:29:10 AM
Ocular Therapeutix (OCUL) Presents Preclinical Data On Pharmacokinetics, Efficacy And Tolerability Of Sustained Release Intravitreal Tyrosine Kinase Inhibitor Hydrogel Depot (OTX-TKI) At The Association for Research in Vision & Ophthalmology Annual Meeting 5/10/2017 7:50:12 AM
Ocular Therapeutix (OCUL) Presents Additional Phase III Data And Patient Reported Outcomes Results For DEXTENZA At American Society of Cataract & Refractive Surgery Symposium 5/8/2017 7:50:28 AM
Ocular Therapeutix (OCUL) Reports First Quarter 2017 Financial Results 5/5/2017 6:05:26 AM
Ocular Therapeutix (OCUL) To Present Data On Anterior And Posterior Segment Drug Product Candidates At Association for Research in Vision & Ophthalmology Annual Meeting 5/2/2017 7:58:11 AM
Ocular Therapeutix (OCUL) To Report First Quarter 2017 Financial Results 5/2/2017 6:34:01 AM
Ocular Therapeutix (OCUL) To Present Additional Phase III Data And Patient Reported Outcomes Results For DEXTENZA At American Society of Cataract & Refractive Surgery Symposium 4/24/2017 7:58:20 AM
12345678910...
//-->